Vermox Market, Global Outlook and Forecast 2022-2028

February 2022 | 63 pages | ID: V6B461061856EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Vermox in Global, including the following market information:

Global Vermox Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Vermox market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Tablet Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Vermox include Johnson & Johnson, Amneal Pharmaceuticals, Cadila Pharmaceuticals, Eipico, Esteve Pharmaceuticals and Tenry, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Vermox companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Vermox Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Vermox Market Segment Percentages, by Type, 2021 (%)

• Tablet
• Oral Suspension

Global Vermox Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Vermox Market Segment Percentages, by Application, 2021 (%)

• Children
• Adult

Global Vermox Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Vermox Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Vermox revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Vermox revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Johnson & Johnson
• Amneal Pharmaceuticals
• Cadila Pharmaceuticals
• Eipico
• Esteve Pharmaceuticals
• Tenry

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Vermox Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Vermox Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL VERMOX OVERALL MARKET SIZE

2.1 Global Vermox Market Size: 2021 VS 2028
2.2 Global Vermox Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Vermox Players in Global Market
3.2 Top Global Vermox Companies Ranked by Revenue
3.3 Global Vermox Revenue by Companies
3.4 Top 3 and Top 5 Vermox Companies in Global Market, by Revenue in 2021
3.5 Global Companies Vermox Product Type
3.6 Tier 1, Tier 2 and Tier 3 Vermox Players in Global Market
  3.6.1 List of Global Tier 1 Vermox Companies
  3.6.2 List of Global Tier 2 and Tier 3 Vermox Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Vermox Market Size Markets, 2021 & 2028
  4.1.2 Tablet
  4.1.3 Oral Suspension
4.2 By Type - Global Vermox Revenue & Forecasts
  4.2.1 By Type - Global Vermox Revenue, 2017-2022
  4.2.2 By Type - Global Vermox Revenue, 2023-2028
  4.2.3 By Type - Global Vermox Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Vermox Market Size, 2021 & 2028
  5.1.2 Children
  5.1.3 Adult
5.2 By Application - Global Vermox Revenue & Forecasts
  5.2.1 By Application - Global Vermox Revenue, 2017-2022
  5.2.2 By Application - Global Vermox Revenue, 2023-2028
  5.2.3 By Application - Global Vermox Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Vermox Market Size, 2021 & 2028
6.2 By Region - Global Vermox Revenue & Forecasts
  6.2.1 By Region - Global Vermox Revenue, 2017-2022
  6.2.2 By Region - Global Vermox Revenue, 2023-2028
  6.2.3 By Region - Global Vermox Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Vermox Revenue, 2017-2028
  6.3.2 US Vermox Market Size, 2017-2028
  6.3.3 Canada Vermox Market Size, 2017-2028
  6.3.4 Mexico Vermox Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Vermox Revenue, 2017-2028
  6.4.2 Germany Vermox Market Size, 2017-2028
  6.4.3 France Vermox Market Size, 2017-2028
  6.4.4 U.K. Vermox Market Size, 2017-2028
  6.4.5 Italy Vermox Market Size, 2017-2028
  6.4.6 Russia Vermox Market Size, 2017-2028
  6.4.7 Nordic Countries Vermox Market Size, 2017-2028
  6.4.8 Benelux Vermox Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Vermox Revenue, 2017-2028
  6.5.2 China Vermox Market Size, 2017-2028
  6.5.3 Japan Vermox Market Size, 2017-2028
  6.5.4 South Korea Vermox Market Size, 2017-2028
  6.5.5 Southeast Asia Vermox Market Size, 2017-2028
  6.5.6 India Vermox Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Vermox Revenue, 2017-2028
  6.6.2 Brazil Vermox Market Size, 2017-2028
  6.6.3 Argentina Vermox Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Vermox Revenue, 2017-2028
  6.7.2 Turkey Vermox Market Size, 2017-2028
  6.7.3 Israel Vermox Market Size, 2017-2028
  6.7.4 Saudi Arabia Vermox Market Size, 2017-2028
  6.7.5 UAE Vermox Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Johnson & Johnson
  7.1.1 Johnson & Johnson Corporate Summary
  7.1.2 Johnson & Johnson Business Overview
  7.1.3 Johnson & Johnson Vermox Major Product Offerings
  7.1.4 Johnson & Johnson Vermox Revenue in Global Market (2017-2022)
  7.1.5 Johnson & Johnson Key News
7.2 Amneal Pharmaceuticals
  7.2.1 Amneal Pharmaceuticals Corporate Summary
  7.2.2 Amneal Pharmaceuticals Business Overview
  7.2.3 Amneal Pharmaceuticals Vermox Major Product Offerings
  7.2.4 Amneal Pharmaceuticals Vermox Revenue in Global Market (2017-2022)
  7.2.5 Amneal Pharmaceuticals Key News
7.3 Cadila Pharmaceuticals
  7.3.1 Cadila Pharmaceuticals Corporate Summary
  7.3.2 Cadila Pharmaceuticals Business Overview
  7.3.3 Cadila Pharmaceuticals Vermox Major Product Offerings
  7.3.4 Cadila Pharmaceuticals Vermox Revenue in Global Market (2017-2022)
  7.3.5 Cadila Pharmaceuticals Key News
7.4 Eipico
  7.4.1 Eipico Corporate Summary
  7.4.2 Eipico Business Overview
  7.4.3 Eipico Vermox Major Product Offerings
  7.4.4 Eipico Vermox Revenue in Global Market (2017-2022)
  7.4.5 Eipico Key News
7.5 Esteve Pharmaceuticals
  7.5.1 Esteve Pharmaceuticals Corporate Summary
  7.5.2 Esteve Pharmaceuticals Business Overview
  7.5.3 Esteve Pharmaceuticals Vermox Major Product Offerings
  7.5.4 Esteve Pharmaceuticals Vermox Revenue in Global Market (2017-2022)
  7.5.5 Esteve Pharmaceuticals Key News
7.6 Tenry
  7.6.1 Tenry Corporate Summary
  7.6.2 Tenry Business Overview
  7.6.3 Tenry Vermox Major Product Offerings
  7.6.4 Tenry Vermox Revenue in Global Market (2017-2022)
  7.6.5 Tenry Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Vermox Market Opportunities & Trends in Global Market
Table 2. Vermox Market Drivers in Global Market
Table 3. Vermox Market Restraints in Global Market
Table 4. Key Players of Vermox in Global Market
Table 5. Top Vermox Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Vermox Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Vermox Revenue Share by Companies, 2017-2022
Table 8. Global Companies Vermox Product Type
Table 9. List of Global Tier 1 Vermox Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Vermox Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Vermox Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Vermox Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Vermox Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Vermox Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Vermox Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Vermox Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Vermox Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Vermox Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Vermox Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Vermox Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Vermox Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Vermox Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Vermox Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Vermox Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Vermox Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Vermox Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Vermox Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Vermox Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Vermox Revenue, (US$, Mn), 2023-2028
Table 30. Johnson & Johnson Corporate Summary
Table 31. Johnson & Johnson Vermox Product Offerings
Table 32. Johnson & Johnson Vermox Revenue (US$, Mn), (2017-2022)
Table 33. Amneal Pharmaceuticals Corporate Summary
Table 34. Amneal Pharmaceuticals Vermox Product Offerings
Table 35. Amneal Pharmaceuticals Vermox Revenue (US$, Mn), (2017-2022)
Table 36. Cadila Pharmaceuticals Corporate Summary
Table 37. Cadila Pharmaceuticals Vermox Product Offerings
Table 38. Cadila Pharmaceuticals Vermox Revenue (US$, Mn), (2017-2022)
Table 39. Eipico Corporate Summary
Table 40. Eipico Vermox Product Offerings
Table 41. Eipico Vermox Revenue (US$, Mn), (2017-2022)
Table 42. Esteve Pharmaceuticals Corporate Summary
Table 43. Esteve Pharmaceuticals Vermox Product Offerings
Table 44. Esteve Pharmaceuticals Vermox Revenue (US$, Mn), (2017-2022)
Table 45. Tenry Corporate Summary
Table 46. Tenry Vermox Product Offerings
Table 47. Tenry Vermox Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Vermox Segment by Type in 2021
Figure 2. Vermox Segment by Application in 2021
Figure 3. Global Vermox Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Vermox Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Vermox Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Vermox Revenue in 2021
Figure 8. By Type - Global Vermox Revenue Market Share, 2017-2028
Figure 9. By Application - Global Vermox Revenue Market Share, 2017-2028
Figure 10. By Region - Global Vermox Revenue Market Share, 2017-2028
Figure 11. By Country - North America Vermox Revenue Market Share, 2017-2028
Figure 12. US Vermox Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Vermox Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Vermox Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Vermox Revenue Market Share, 2017-2028
Figure 16. Germany Vermox Revenue, (US$, Mn), 2017-2028
Figure 17. France Vermox Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Vermox Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Vermox Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Vermox Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Vermox Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Vermox Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Vermox Revenue Market Share, 2017-2028
Figure 24. China Vermox Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Vermox Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Vermox Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Vermox Revenue, (US$, Mn), 2017-2028
Figure 28. India Vermox Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Vermox Revenue Market Share, 2017-2028
Figure 30. Brazil Vermox Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Vermox Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Vermox Revenue Market Share, 2017-2028
Figure 33. Turkey Vermox Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Vermox Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Vermox Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Vermox Revenue, (US$, Mn), 2017-2028
Figure 37. Johnson & Johnson Vermox Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Amneal Pharmaceuticals Vermox Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Cadila Pharmaceuticals Vermox Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Eipico Vermox Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Esteve Pharmaceuticals Vermox Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Tenry Vermox Revenue Year Over Year Growth (US$, Mn) & (2017-2022)